# Residual Inflammatory Risk-Guided colcHicine in Elderly Trial

> **NCT06025071** · PHASE4 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 800 (estimated)

## Conditions studied

- Percutaneous Coronary Intervention
- Multivessel Coronary Artery Disease
- Elderly Patients
- C-Reactive Protein

## Interventions

- **DRUG:** colchicine

## Key facts

- **NCT ID:** NCT06025071
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2025-09
- **Final completion:** 2025-10
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025071, "Residual Inflammatory Risk-Guided colcHicine in Elderly Trial". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06025071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*